SFU

Glucose Range Monitoring System

Product code
SFU
Device name
Glucose Range Monitoring System
Device class
Class 2
21 CFR
21 CFR 862.1359
Medical specialty
Clinical Chemistry
Marketing pathway
510(K)
510(k) clearances (last 3 years)
1
Summaries archived here
0 (direct download)
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

A glucose range monitoring system (GRM) is intended to automatically measure glucose in the body and provide qualitative or semi-quantitative information about glucose levels or trends continuously or frequently. GRM systems are intended to support general user awareness of glucose ranges related to glycemic control. Outputs from GRM systems do not represent quantitative glucose concentration values and GRM systems are not intended to be used for acute medical decision-making, such as insulin dosing or medication adjustment.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2025-09-23.

NumberDecision dateApplicantDevice nameSummary
DEN2400802025-09-23Biolinq IncorporatedBiolinq Shine Autonomous Time-in-Range Microsensor
Official FDA classification page: SFU
Classification and pathway per current FDA publications. Data from openFDA (CC0).